PSUSA/00002564/202510
Submitted by Anonymous (not verified) on 16 June 2026 - 11:22
PSUSA/00002564/202510
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 16 June 2026 - 11:16
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Process for the electronic submission of medicinal product information - Chapter 3
Submitted by Anonymous (not verified) on 16 June 2026 - 10:48
Process for the electronic submission of medicinal product information - Chapter 3
Elsevier Launches Ebola Information Center
Submitted by Catalina on 16 June 2026 - 9:45
An Ebola Information Center has been launched by Elsevier in response to the World Health Organization's recent declaration of Ebola as an international public health emergency. This Information Center provides free access to all Ebola-related content across Elsevier’s journals, medical books and clinical resources.
Committee for Advanced Therapies (CAT) rules of procedure
Submitted by Anonymous (not verified) on 16 June 2026 - 9:00
Committee for Advanced Therapies (CAT) rules of procedure
PSUSA/00000967/202509
Submitted by Anonymous (not verified) on 16 June 2026 - 8:58
PSUSA/00000967/202509
PSUSA/00001786/202510
Submitted by Anonymous (not verified) on 16 June 2026 - 8:56
PSUSA/00001786/202510
PSUSA/00010735/202510
Submitted by Anonymous (not verified) on 16 June 2026 - 8:55
PSUSA/00010735/202510
PSUSA/00000236/202510
Submitted by Anonymous (not verified) on 16 June 2026 - 8:53
PSUSA/00000236/202510
PSUSA/00000165/202510
Submitted by Anonymous (not verified) on 16 June 2026 - 8:50
PSUSA/00000165/202510